MEDIFAST INC (MED)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 600M 1.2B 1.8B FY09: 169.7M FY10: 257.6M FY11: 298.2M FY12: 318.6M FY13: 324.1M FY14: 285.3M FY15: 272.8M FY16: 274.5M FY17: 301.6M FY18: 501M FY19: 713.7M FY20: 934.8M FY21: 1.5B FY22: 1.6B FY23: 1.1B FY24: 602.5M FY25: 385.8M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 400M 800M 1.2B FY09: 124.4M FY10: 192.5M FY11: 224.5M FY12: 235.9M FY13: 240.6M FY14: 209.2M FY15: 201.3M FY16: 205.7M FY17: 227.8M FY18: 379.9M FY19: 536.9M FY20: 697.8M FY21: 1.1B FY22: 1.1B FY23: 775.9M FY24: 444.6M FY25: 275.2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-80M 0 80M 160M 240M FY09: 18.5M FY10: 31.6M FY11: 27.4M FY12: 27.1M FY13: 38.4M FY14: 30.2M FY15: 28.7M FY16: 26.9M FY17: 39.6M FY18: 69.1M FY19: 91M FY20: 134.2M FY21: 216.2M FY22: 184.8M FY23: 126.4M FY24: 2.9M FY25: -14.2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-60M 0 60M 120M 180M FY09: 11.4M FY10: 19.6M FY11: 18.5M FY12: 15.9M FY13: 24M FY14: 13.2M FY15: 20.1M FY16: 17.8M FY17: 27.7M FY18: 55.8M FY19: 77.9M FY20: 102.9M FY21: 164M FY22: 143.6M FY23: 99.4M FY24: 2.1M FY25: -18.7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 200M 400M 600M FY09: 45.4M FY10: 65.1M FY11: 73.7M FY12: 82.7M FY13: 83.5M FY14: 76.1M FY15: 71.5M FY16: 68.9M FY17: 73.8M FY18: 121.1M FY19: 176.8M FY20: 237M FY21: 398.5M FY22: 458.2M FY23: 296.2M FY24: 157.8M FY25: 110.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 70M 140M 210M FY09: 19.2M FY10: 28.8M FY11: 34.9M FY12: 40.3M FY13: 42.4M FY14: 25.5M FY15: 29.4M FY16: 25.4M FY17: 43.2M FY18: 60.8M FY19: 84.3M FY20: 145.2M FY21: 94.5M FY22: 194.6M FY23: 147.7M FY24: 24.5M FY25: 6.9M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 70M 140M 210M FY09: 14M FY10: 16.7M FY11: 20.6M FY12: 32.1M FY13: 31M FY14: 18.5M FY15: 26.6M FY16: 22.5M FY17: 40M FY18: 55.9M FY19: 74.2M FY20: 139.3M FY21: 60.3M FY22: 177.9M FY23: 141.2M FY24: 17M FY25: 1.2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 6M 12M 18M FY09: 14.7M FY10: 14.6M FY11: 14.2M FY12: 13.7M FY13: 13.8M FY14: 12.8M FY15: 12.1M FY16: 11.9M FY17: 12.1M FY18: 12.1M FY19: 12.1M FY20: 11.8M FY21: 11.8M FY22: 11.3M FY23: 10.9M FY24: 11M FY25: 11M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-5.00 0.00 5.00 10.00 15.00 Q4 '10: 1.35 Q1 '11: 1.45 Q2 '11: 1.48 Q3 '11: 1.45 Q4 '11: 1.30 Q1 '12: 1.15 Q2 '12: 0.94 Q3 '12: 1.10 Q4 '12: 1.15 Q1 '13: 1.29 Q2 '13: 1.60 Q3 '13: 1.49 Q4 '13: 1.74 Q1 '14: 1.76 Q2 '14: 1.69 Q3 '14: 1.67 Q4 '15: 1.66 Q1 '16: 1.66 Q2 '16: 1.44 Q3 '16: 1.49 Q4 '16: 1.50 Q1 '17: 1.65 Q2 '17: 1.99 Q3 '17: 2.03 Q4 '17: 2.29 Q1 '18: 2.79 Q2 '18: 3.32 Q3 '18: 3.91 Q4 '18: 4.61 Q1 '19: 5.30 Q2 '19: 5.89 Q3 '19: 6.07 Q4 '19: 6.43 Q1 '20: 6.29 Q2 '20: 6.40 Q3 '20: 7.99 Q4 '20: 8.69 Q1 '21: 10.59 Q2 '21: 12.69 Q3 '21: 13.34 Q4 '21: 13.89 Q1 '22: 14.02 Q2 '22: 13.48 Q3 '22: 13.19 Q4 '22: 12.71 Q1 '23: 12.79 Q2 '23: 12.14 Q3 '23: 10.99 Q4 '23: 9.11 Q1 '24: 6.20 Q2 '24: 2.68 Q3 '24: 0.66 Q4 '24: 0.19 Q1 '25: -0.64 Q2 '25: 0.33 Q3 '25: 0.02 Q4 '25: -1.71 Q1 '26: -1.83 Q2 '26: -2.33 Q2 '11 Q2 '13 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.